Iron isomaltoside — Competitive Intelligence Brief

Iron isomaltoside (Iron isomaltoside) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Hematology.

marketed Iron replacement agent Iron (Fe3+) / transferrin receptor Hematology Small molecule

Target snapshot

Iron isomaltoside (Iron isomaltoside) — Thomas Jefferson University. Iron isomaltoside is an iron replacement therapy that delivers ferric iron complexed with isomaltoside, allowing efficient absorption and utilization for hemoglobin synthesis in iron-deficient patients.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iron isomaltoside TARGET	Iron isomaltoside	Thomas Jefferson University	marketed	Iron replacement agent	Iron (Fe3+) / transferrin receptor
Iron Sucrose (Venofer)	Iron Sucrose (Venofer)	American Regent, Inc.	marketed	Intravenous iron replacement agent
Brand sodium ferric gluconate	Brand sodium ferric gluconate	University of Maryland, Baltimore	marketed	Iron replacement agent
Iron Sucrose IV	Iron Sucrose IV	CN NGANOU-GNINDJIO, MD, MSc	marketed	Iron replacement agent	Transferrin receptor (indirect); iron supplementation
Sodium ferric gluconate	Sodium ferric gluconate	University of North Carolina, Chapel Hill	marketed	Iron replacement agent	Iron (Fe3+) delivery system
Venofer®	Venofer®	Azad Pharma AG	marketed	Iron replacement agent
venoferrum(iron sucrose)	venoferrum(iron sucrose)	JW Pharmaceutical	marketed	Iron replacement agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

1. University of Maryland, Baltimore · 2 drugs in this class
2. Ain Shams University · 1 drug in this class
3. American Regent, Inc. · 1 drug in this class
4. Azad Pharma AG · 1 drug in this class
5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
6. China-Japan Friendship Hospital · 1 drug in this class
7. Hallym University Medical Center · 1 drug in this class
8. J. Uriach and Company · 1 drug in this class
9. JW Pharmaceutical · 1 drug in this class
10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class